Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
114.65
+0.11 (0.10%)
Jun 6, 2025, 2:45 PM CST

SHA:688266 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
30,42016,49414,01410,00814,11215,526
Upgrade
Market Cap Growth
85.05%17.70%40.02%-29.08%-9.11%-
Upgrade
Enterprise Value
29,28615,21312,6589,44313,02813,956
Upgrade
Last Close Price
114.9262.3152.9441.7058.8064.69
Upgrade
Forward PE
-35.5135.5135.51--
Upgrade
PS Ratio
51.3630.9536.2633.1174.13561.28
Upgrade
PB Ratio
24.8613.178.5212.7111.269.18
Upgrade
P/TBV Ratio
25.7613.708.9614.9813.0710.43
Upgrade
P/OCF Ratio
-431.73----
Upgrade
EV/Sales Ratio
49.4428.5432.7631.2468.44504.55
Upgrade
Debt / Equity Ratio
0.820.830.540.700.180.03
Upgrade
Asset Turnover
0.200.180.170.180.100.02
Upgrade
Inventory Turnover
0.340.260.300.370.190.04
Upgrade
Quick Ratio
1.721.712.081.573.3511.37
Upgrade
Current Ratio
1.881.882.221.773.6911.85
Upgrade
Return on Equity (ROE)
-9.56%-10.37%-24.27%-47.59%-31.38%-35.20%
Upgrade
Return on Assets (ROA)
-4.19%-4.60%-10.91%-19.70%-17.02%-20.80%
Upgrade
Return on Capital (ROIC)
-5.22%-5.62%-12.84%-23.92%-19.64%-25.32%
Upgrade
Earnings Yield
-0.42%-0.84%-1.99%-4.57%-3.20%-2.06%
Upgrade
FCF Yield
-0.51%-0.35%-2.11%-4.59%-3.72%-2.59%
Upgrade
Buyback Yield / Dilution
-0.63%-3.71%-6.74%0.19%-2.20%-30.61%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.